Enlivex Therapeutics Faces Financial Uncertainty Amid Biotech Ambitions
Enlivex Therapeutics Ltd’s financial metrics and market performance raise concerns about its viability and future prospects, despite its promising pipeline and mission to tackle immune hyper-responses.
3 minutes to read